Up-regulation of IL-23 p19 expression in human periodontal ligament fibroblasts by IL-1β via concurrent activation of the NF-κB and MAPKs/AP-1 pathways

Cytokine

Volumn 60, Issue 1, 2012, Pages 171-178

  Zhu, Lingxin ^a   Wu, Yan ^a   Wei, Hongxia ^a   Yang, Shasha ^a   Zhan, Ni ^a   Xing, Xin ^a   Peng, Bin ^a  

^a Wuhan University   (China)

Author keywords

IL 1; IL 23; Periodontal ligament fibroblasts; Periodontitis

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 23P19; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; PERIODONTAL LIGAMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TH17 CELL; UPREGULATION;

ANTHRACENES; BLOTTING, WESTERN; CELLS, CULTURED; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; FLAVONOIDS; GENE EXPRESSION REGULATION; HUMANS; IMIDAZOLES; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; INTERLEUKIN-23 SUBUNIT P19; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICROSCOPY, FLUORESCENCE; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PERIODONTAL LIGAMENT; PYRIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTOR RELA; UP-REGULATION;

EID: 84865405884     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.05.016     Document Type: Article

References (34)

1. Bartold P.M., Cantley M.D., Haynes D.R. Mechanisms and control of pathologic bone loss in periodontitis. Periodontology 2000, 2010(53):55-69.
2. Cochran D.L. Inflammation and bone loss in periodontal disease. J Periodontol 2008, 79:1569-1576.
3. Boniface K., Blom B., Liu Y.J., de Waal Malefyt R. From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited. Immunol Rev 2008, 226:132-146.
4. Gee K., Guzzo C., Che Mat N.F., Ma W., Kumar A. The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. Inflamm Allergy Drug Targets 2009, 8:40-52.
5. Ohyama H., Kato-Kogoe N., Kuhara A., Nishimura F., Nakasho K., Yamanegi K., et al. The involvement of IL-23 and the Th17 pathway in periodontitis. J Dent Res 2009, 88:633-638.
6. Yucel O.O., Berker E., Gariboglu S., Otlu H. Interleukin-11, interleukin-1beta, interleukin-12 and the pathogenesis of inflammatory periodontal diseases. J Clin Periodontol 2008, 35:365-370.
7. Lester S.R., Bain J.L., Johnson R.B., Serio F.G. Gingival concentrations of interleukin-23 and -17 at healthy sites and at sites of clinical attachment loss. J Periodontol 2007, 78:1545-1550.
8. Alayan J., Gemmell E., Ford P., Hamlet S., Bird P.S., Ivanovski S., et al. The role of cytokines in a Porphyromonas gingivalis-induced murine abscess model. Oral Microbiol Immunol 2007, 22:304-312.
9. Cardoso C.R., Garlet G.P., Crippa G.E., Rosa A.L., Junior W.M., Rossi M.A., et al. Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease. Oral Microbiol Immunol 2009, 24:1-6.
10. Dutzan N., Gamonal J., Silva A., Sanz M., Vernal R. Over-expression of forkhead box P3 and its association with receptor activator of nuclear factor-kappaB ligand, interleukin (IL)-17, IL-10 and transforming growth factor-beta during the progression of chronic periodontitis. J Clin Periodontol 2009, 36:396-403.
11. Schenkein H.A., Koertge T.E., Brooks C.N., Sabatini R., Purkall D.E., Tew J.G. IL-17 in sera from patients with aggressive periodontitis. J Dent Res 2010, 89:943-947.
12. El-Awady A.R., Messer R.L., Gamal A.Y., Sharawy M.M., Wenger K.H., Lapp C.A. Periodontal ligament fibroblasts sustain destructive immune modulators of chronic periodontitis. J Periodontol 2010, 81:1324-1335.
13. Zhu L., Wu Y., Wei H., Xing X., Zhan N., Xiong H., et al. IL-17R activation of human periodontal ligament fibroblasts induces IL-23 p19 production: differential involvement of NF-kappaB versus JNK/AP-1 pathways. Mol Immunol 2011, 48:647-656.
14. Adamopoulos I.E., Tessmer M., Chao C.C., Adda S., Gorman D., Petro M., et al. IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass. J Immunol 2011, 187:951-959.
15. Carmody R.J., Ruan Q., Liou H.C., Chen Y.H. Essential roles of c-Rel in TLR-induced IL-23 p19 gene expression in dendritic cells. J Immunol 2007, 178:186-191.
16. Dobreva Z.G., Stanilova S.A., Miteva L.D. Differences in the inducible gene expression and protein production of IL-12 p40, IL-12 p70 and IL-23: involvement of p38 and JNK kinase pathways. Cytokine 2008, 43:76-82.
17. Kim H.R., Cho M.L., Kim K.W., Juhn J.Y., Hwang S.Y., Yoon C.H., et al. Up-regulation of IL-23 p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-kappaB- and p38 MAPK-dependent signalling pathways. Rheumatology (Oxford) 2007, 46:57-64.
18. Yang C.S., Song C.H., Lee J.S., Jung S.B., Oh J.H., Park J., et al. Intracellular network of phosphatidylinositol 3-kinase, mammalian target of the rapamycin/70 kDa ribosomal S6 kinase 1, and mitogen-activated protein kinases pathways for regulating mycobacteria-induced IL-23 expression in human macrophages. Cell Microbiol 2006, 8:1158-1171.
19. Zhang Z., Andoh A., Yasui H., Inatomi O., Hata K., Tsujikawa T., et al. Interleukin-1beta and tumor necrosis factor-alpha up-regulate interleukin-23 subunit p19 gene expression in human colonic subepithelial myofibroblasts. Int J Mol Med 2005, 15:79-83.
20. Duvallet E., Semerano L., Assier E., Falgarone G., Boissier M.C. Interleukin-23: a key cytokine in inflammatory diseases. Ann Med 2011, 43:503-511.
21. Murphy C.A., Langrish C.L., Chen Y., Blumenschein W., McClanahan T., Kastelein R.A., et al. Divergent pro- and anti-inflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 2003, 198:1951-1957.
22. Strand V., Kavanaugh A.F. The role of interleukin-1 in bone resorption in rheumatoid arthritis. Rheumatology (Oxford) 2004, 43(Suppl. 3):iii10-iii16.
23. Ataoglu T., Ungor M., Serpek B., Haliloglu S., Ataoglu H., Ari H. Interleukin-1beta and tumour necrosis factor-alpha levels in periapical exudates. Int Endod J 2002, 35:181-185.
24. Silva A.C., Faria M.R., Fontes A., Campos M.S., Cavalcanti B.N. Interleukin-1 beta and interleukin-8 in healthy and inflamed dental pulps. J Appl Oral Sci 2009, 17:527-532.
25. Graves D.T., Delima A.J., Assuma R., Amar S., Oates T., Cochran D. Interleukin-1 and tumor necrosis factor antagonists inhibit the progression of inflammatory cell infiltration toward alveolar bone in experimental periodontitis. J Periodontol 1998, 69:1419-1425.
26. Chung Y., Chang S.H., Martinez G.J., Yang X.O., Nurieva R., Kang H.S., et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signalling. Immunity 2009, 30:576-587.
27. Bartold P.M., Narayanan A.S. Molecular and cell biology of healthy and diseased periodontal tissues. Periodontology 2000, 2006(40):29-49.
28. Allam J.P., Duan Y., Heinemann F., Winter J., Gotz W., Deschner J., et al. IL-23-producing CD68(+) macrophage-like cells predominate within an IL-17-polarized infiltrate in chronic periodontitis lesions. J Clin Periodontol 2011, 38:879-886.
29. Boch J.A., Wara-aswapati N., Auron P.E. Interleukin 1 signal transduction-current concepts and relevance to periodontitis. J Dent Res 2001, 80:400-407.
30. Liu W., Ouyang X., Yang J., Liu J., Li Q., Gu Y., et al. AP-1 activated by toll-like receptors regulates expression of IL-23 p19. J Biol Chem 2009, 284:24006-24016.
31. Petro T.M. ERK-MAP-kinases differentially regulate expression of IL-23 p19 compared with p40 and IFN-beta in Theiler's virus-infected RAW 264.7 cells. Immunol Lett 2005, 97:47-53.
32. Li Y., Chu N., Hu A., Gran B., Rostami A., Zhang G.X. Inducible IL-23 p19 expression in human microglia via p38 MAPK and NF-kappaB signalling pathways. Exp Mol Pathol 2008, 84:1-8.
33. Zhang R., Wang L., Peng B. Activation of p38 mitogen-activated protein kinase in rat periapical lesions. J Endod 2008, 34:1207-1210.
34. Kirkwood K.L., Li F., Rogers J.E., Otremba J., Coatney D.D., Kreider J.M., et al. A p38alpha selective mitogen-activated protein kinase inhibitor prevents periodontal bone loss. J Pharmacol Exp Ther 2007, 320:56-63.